Speakers




Andrew J. Cutler, MD
Industry Symposium With ACPE Credit Not So Positive: Treating the Negative and Cognitive Symptoms of Schizophrenia Supported by Boehringer Ingelheim
Industry Symposium With ACPE Credit Don’t Get Mixed Up! Recognizing and Treating Mixed Features Across the Lifespan Supported by Intra-Cellular Therapies
Industry Symposium With ACPE Credit Not So Positive: Treating the Negative and Cognitive Symptoms of Schizophrenia Supported by Boehringer Ingelheim
Industry Symposium With ACPE Credit Don’t Get Mixed Up! Recognizing and Treating Mixed Features Across the Lifespan Supported by Intra-Cellular Therapies





Chelsea Di Polito, PharmD, BCPP
The Good, the Bad, and the Unknown of Psychotropic Stewardship Implementation: A Focus on Antipsychotics
The Good, the Bad, and the Unknown of Psychotropic Stewardship Implementation: A Focus on Antipsychotics









Katharine "Kaz" Joyer Nelson, MD, DFAPA
Evidence-based Management of Borderline Personality Disorder
Evidence-based Management of Borderline Personality Disorder


Kristen Ward, PharmD, BCPP
Using Pharmacogenomics to Optimize Mental Health Comprehensive Medication Management
Using Pharmacogenomics to Optimize Mental Health Comprehensive Medication Management






Moderator: Megan Ehret, PharmD, MS, BCPP
Industry Showcase Practical Learnings and Knowledge When Implementing Rapid TDM Blood Levels: A Focus on Clozapine and Beyond Supported by Saladax Biomedical
Industry Showcase Practical Learnings and Knowledge When Implementing Rapid TDM Blood Levels: A Focus on Clozapine and Beyond Supported by Saladax Biomedical




Shari N. Allen, PharmD, BCPP
Social Determinants of Health in the Treatment of Depression
Clinical Pearls 1
Social Determinants of Health in the Treatment of Depression
Clinical Pearls 1

Speaker: Georgios Schoretsanitis, MD, PhD
Industry Showcase Practical Learnings and Knowledge When Implementing Rapid TDM Blood Levels: A Focus on Clozapine and Beyond Supported by Saladax Biomedical
Industry Showcase Practical Learnings and Knowledge When Implementing Rapid TDM Blood Levels: A Focus on Clozapine and Beyond Supported by Saladax Biomedical


Steven W. Shoyer, PharmD, BCPP
Identification and Management of Illicit Substance Use (xylazine, fentanyl, kratom)
Identification and Management of Illicit Substance Use (xylazine, fentanyl, kratom)

Tiffany R Buckley, PharmD, BCPS, BCPP
Role of Cannabis and Cannabidiol in the Treatment of Anxiety Disorders
Role of Cannabis and Cannabidiol in the Treatment of Anxiety Disorders

Veronica Vernon, PharmD, BCPS, BCACP, MSCP
Integrating Contraceptive Care in Psychiatry: Best Practices
Integrating Contraceptive Care in Psychiatry: Best Practices
